Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension
- 30 November 2007
- journal article
- research article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 101 (11), 2254-2262
- https://doi.org/10.1016/j.rmed.2007.06.027
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Medical Therapies for Chronic Thromboembolic Pulmonary Hypertension: An Evolving Treatment ParadigmProceedings of the American Thoracic Society, 2006
- Assessment of Operability in Chronic Thromboembolic Pulmonary HypertensionProceedings of the American Thoracic Society, 2006
- Chronic Thromboembolic Pulmonary HypertensionCirculation, 2006
- Pulmonary endarterectomy: experience and lessons learned in 1,500 casesThe Annals of Thoracic Surgery, 2003
- Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomyThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary HypertensionCirculation, 2000
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.JCI Insight, 1991
- Longterm Follow-up of Patients with Pulmonary ThromboembolismSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1982